Shucai Wu

662 total citations
22 papers, 453 citations indexed

About

Shucai Wu is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Shucai Wu has authored 22 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Shucai Wu's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Pneumonia and Respiratory Infections (4 papers). Shucai Wu is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Pneumonia and Respiratory Infections (4 papers). Shucai Wu collaborates with scholars based in China and United States. Shucai Wu's co-authors include Xinyan Liu, Yonghui Yang, Guiyun Zhu, Min Zhao, Yi Dang, Yongjun Wang, Jianzhen Liu, Yang Hong, Wei Liu and Wu‐Chun Cao and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Infection and Immunity.

In The Last Decade

Shucai Wu

21 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shucai Wu China 8 190 170 144 141 134 22 453
Chang Song China 9 292 1.5× 93 0.5× 210 1.5× 59 0.4× 299 2.2× 25 665
Guillaume Herbreteau France 10 108 0.6× 122 0.7× 162 1.1× 158 1.1× 68 0.5× 22 345
Iris Mimpen United States 3 309 1.6× 72 0.4× 372 2.6× 53 0.4× 211 1.6× 3 611
Ping Zhan China 10 271 1.4× 88 0.5× 97 0.7× 213 1.5× 39 0.3× 27 463
Hong-Xin Peng China 12 186 1.0× 66 0.4× 158 1.1× 174 1.2× 45 0.3× 19 420
Klaudia Szymonowicz United States 8 232 1.2× 95 0.6× 126 0.9× 83 0.6× 53 0.4× 9 483
Angela Alistar United States 11 253 1.3× 72 0.4× 256 1.8× 180 1.3× 196 1.5× 48 630
Jingli Du China 9 220 1.2× 71 0.4× 40 0.3× 115 0.8× 60 0.4× 18 350
Philippe Legenne United Kingdom 8 287 1.5× 119 0.7× 362 2.5× 35 0.2× 49 0.4× 29 516
Umberto Conte United States 11 106 0.6× 154 0.9× 150 1.0× 46 0.3× 21 0.2× 27 360

Countries citing papers authored by Shucai Wu

Since Specialization
Citations

This map shows the geographic impact of Shucai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shucai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shucai Wu more than expected).

Fields of papers citing papers by Shucai Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shucai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shucai Wu. The network helps show where Shucai Wu may publish in the future.

Co-authorship network of co-authors of Shucai Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shucai Wu. A scholar is included among the top collaborators of Shucai Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shucai Wu. Shucai Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shucai, et al.. (2024). In vivo and in vitro Models of PM2.5 Induced COPD: Focus on the Role of RTA-408. International Journal of COPD. Volume 19. 2239–2257. 2 indexed citations
2.
Zhang, Zhihua, et al.. (2024). Fascin Inhibitor NP-G2-044 Decreases Cell Metastasis while Increases Overall Survival of Mice-bearing Lung Cancers. Current Molecular Medicine. 25(8). 1038–1047. 2 indexed citations
3.
Chen, Jingyu, Chen Li, Xiang Wang, et al.. (2023). The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis. Technology in Cancer Research & Treatment. 22. 2223908642–2223908642. 5 indexed citations
4.
Xu, Xiaolong, Yadong Yuan, Rongmeng Jiang, et al.. (2022). Effectiveness of Lianhua Qingwen Capsule in Treatment of Asymptomatic COVID-19 Patients: A Randomized, Controlled Multicenter Trial. Journal of Integrative and Complementary Medicine. 28(11). 887–894. 9 indexed citations
5.
Zhang, Ling, Xiaolong Xu, Yadong Yuan, et al.. (2022). Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical Study. Evidence-based Complementary and Alternative Medicine. 2022. 1–9. 10 indexed citations
6.
Wu, Shucai, Jiawen Zhang, Hongyan Wei, et al.. (2022). Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer. Current Cancer Drug Targets. 23(7). 534–546. 3 indexed citations
7.
Li, Zhihui, et al.. (2021). Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB. Scientific Reports. 11(1). 14516–14516. 10 indexed citations
8.
Liu, Shengsheng, Meiying Wu, Shucai Wu, et al.. (2021). Factors associated with differential T cell responses to antigens ESAT-6 and CFP-10 in pulmonary tuberculosis patients. Medicine. 100(8). e24615–e24615. 3 indexed citations
9.
10.
Chen, Yuxin, Xiaojin Liu, Xun Zhang, et al.. (2020). Longitudinal cerebrospinal fluid assessment in a patient with tuberculous meningitis—A case report. Journal of Clinical Laboratory Analysis. 34(7). e23286–e23286. 3 indexed citations
11.
12.
Li, Jing, et al.. (2019). Attention on Smoking Status to PD-1/PD-L1 Drugs on Non-Small Lung Cancer Patients. 3(4). 1 indexed citations
13.
Wu, Meiying, Shucai Wu, Zhihui Li, et al.. (2018). Factors associated with negative T-SPOT.TB results among smear-negative tuberculosis patients in China. Scientific Reports. 8(1). 4236–4236. 6 indexed citations
14.
Wang, Guirong, Meiying Wu, Shucai Wu, et al.. (2018). Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings. Chinese Medical Journal. 131(3). 268–275. 14 indexed citations
15.
Martin, Michael G., et al.. (2018). Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer. Journal of Cancer. 9(7). 1287–1300. 12 indexed citations
16.
Liu, Xinyan, et al.. (2018). Construction of High Sensitive CD133 Immune PLGA Magnetic Spheres Platform for Lung Cancer Stem Cells Isolation and Its Property Evaluation. Journal of Biomedical Nanotechnology. 14(6). 1066–1074. 3 indexed citations
17.
Liu, Xinyan, et al.. (2017). The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer. Biomedicine & Pharmacotherapy. 95. 55–61. 257 indexed citations
18.
Wang, Yongjun, et al.. (2017). Long intergenic non-coding RNA 00152 promotes renal cell carcinoma progression by epigenetically suppressing P16 and negatively regulates miR-205.. PubMed. 7(2). 312–322. 44 indexed citations
19.
20.
Ma, Mai‐Juan, Shucai Wu, Fang Tang, et al.. (2010). Toll-like receptors, tumor necrosis factor–α, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity. Human Immunology. 71(10). 1005–1010. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang Song Breakdown of academic impact, for papers by Guillaume Herbreteau Breakdown of academic impact, for papers by Iris Mimpen Breakdown of academic impact, for papers by Ping Zhan Breakdown of academic impact, for papers by Hong-Xin Peng Breakdown of academic impact, for papers by Klaudia Szymonowicz Breakdown of academic impact, for papers by Angela Alistar Breakdown of academic impact, for papers by Jingli Du Breakdown of academic impact, for papers by Philippe Legenne Breakdown of academic impact, for papers by Umberto Conte
Rankless by CCL
2026